NNMT Is an Immune-Related Prognostic Biomarker That Modulates the Tumor Microenvironment in Pan-Cancer

Figure 2

Association of NNMT expression level with different pathological stages. The expression levels of the NNMT were analyzed by the pathological stages (stages I, II, III, and IV) of ACC, BLCA, BRCA, ESCA, KIRC, OV, STAD, TGCT, and THCA from TCGA database in GEPIA. Log2 (TPM+1) was applied for log-scale. ACC: adrenocortical carcinoma; BLCA: bladder urothelial carcinoma; BRCA: breast invasive carcinoma; ESCA: esophageal carcinoma; GEPIA: Gene Expression Profiling Interactive Analysis; KIRC, kidney renal clear cell carcinoma; NNMT, nicotinamide N-methyltransferase; OV, ovarian serous cystadenocarcinoma; STAD, stomach adenocarcinoma; TGCT, testicular germ cell tumors; THCA, thyroid carcinoma; TPM, transcripts per million.